Small-animal models are extensively used in disease research, genomics research, drug development, and developmental biology. The development of noninvasive small-animal imaging techniques with adequate spatial resolution and sensitivity is therefore of prime important. In particular, multimodality small-animal imaging can provide complementary information. This paper presents the role of high frequency ultrasound (microUS) in multimodality small animal imaging for cancer research and some new trends to implement microUS and small-animal positron-emission tomography (microPET) multimodality small animal imaging. The new trends of combining these two imaging systems were extended to perform other imaging systems. Firstly, registration of microUS/microPET is performed using a three-dimensional registration method. In addition, microUS was combined with microPET for tumor progressive assessment. MicroUS provides anatomical information which can be used for tumor volume measurements while microPET is a functional imaging method with positron-emitting radiophamaceuticals, such as 
Introduction
The early and accurate diagnosis of cancer improves the prognosis for treatment. It is very important either in chemotherapy or in radiotherapy planning. To achieve this purpose, the combination of molecular-functional-anatomic multiple imaging modalities provides the highest advantage of noninvasive method because each image modality has its own strengths and weaknesses. Depending on this reason; combining anatomical and functional images was obvious to physicians in the 1960s [1] . The advantage of multimodality images, such as positron-emission tomography-computed tomography (PET/CT) (introduced 2001) and single photon emission computed tomography-computed tomography (SPECT/CT) (introduced 2004) is that the CT can be used to adjust the functional images (PET and SPECT) for attenuation [2, 3] and scatter [4] . Thus, the progression of multimodality image technique is rapidly and widely applied for oncology. In 2006, there were about 21 million SPECT studies performed in ultrasound (US) compared with 1.5 million PET and PET/CT studies [5] . However, for PET/CT or SPECT/CT, simultaneous imaging of the anatomy and the nuclear medicine distribution covering the same region of the patient is not possible. On the other hand, magnetic resonance imaging (MRI)/PET for the brain allows simultaneous acquisition of both modalities, potentially creating new research applications for neuro imaging. Recently, whole body MRI/PET and PET/US for breast imaging have extended the range of clinical multimodality technology [5] .
Small-animal positron-emission tomography (microPET and microcomputed tomography (microCT) have become essential tools for evaluating new therapeutic approaches in animal models of human disease [6] . However, combining of ultrasound with other imaging systems is not commonly discussed. Ultrasound can provide the structure and the microcirculation information for the therapeutic effects of cancer. In this paper, microUS and microPET multimodality imaging is demonstrated as an alternative method which can provide complementary information. The new trends and the role of microUS in multimodality small animal imaging for cancer research are discussed in this paper.
High frequency ultrasound is refers to the frequency range above 20 MHz [7] [8] [9] . MicroUS is an important tool for obtaining non-invasive real-time images of small animals. A spatial resolution of less than 100 μm can be achieved if high-frequency ultrasound is used. PET provides three dimensional (3D) distribution of positron-emitting radiopharmaceuticals. Using radiolabeled biomolecules and kinetics models, PET can be utilized for quantitative measurements of many metabolic functions in living animals, such as in the brain, heart or in tumors. For small animal studies, microPET [10, 11] was designed with an improved spatial resolution over clinical PET. The spatial resolution of microPET (R4, Concord Microsystems, Knoxville, TN, USA) was about 1.8 mm at the center of the field of view and dropped to 2.5 mm (radial component) at 25 mm off-center [12] . Our previous studies showed that the realtime anatomical information with high-resolution combined with functional information can be obtained simultaneously by integrating microUS and microPET systems.
An effective registration method is necessary since it is difficult to perform both imaging procedures simultaneously with a known geometrical relationship between them. Nevertheless, the imaging process is more limited in high resolution small animal imaging systems than in clinical imaging systems. MicroUS and microPET were performed in a mouse tumor longitudinal study (2-8 weeks), both with 3D tumor segmentation and volume measurements. To investigate the effectiveness of the microUS functional imaging, the contrast enhanced microUS tumor imaging was used to detect three vascular contrast phases and characterize malignant focal liver lesions. Contrast enhanced ultrasound (CEUS) imaging has been a reliable clinical method of detecting three vascular contrast phases and characterizing focal liver lesions. Ultrasound contrast agents strongly increase the ultrasound backscatter and therefore are useful in the enhancement of blood echogenicity for the assessment of blood flow in the vasculature, however all of these studies have been performed in humans and not small animals [13] [14] [15] [16] [17] [18] . CEUS are generally based on the cancellation and/or separation of linear ultrasound signals from tissue and utilization of the nonlinear response from microbubbles [19] [20] [21] [22] . Recently, the HilbertHuang transform (HHT), first introduced by Huang et al in 1998 [23] , has been used extensively in the analysis of nonlinear and non-stationary signals. This paper also demonstrates the contrasting improvement in ultrasound nonlinear imaging using a new ensemble empirical mode decomposition of HHT. The application of the new technique was expected to enhance the effectiveness of CEUS in tumor imaging.
Registration Method for MicroUS/ MicroPET Multimodality Small-Animal Imaging
Image registration is the most significant move towards the combination of various image modalities. Medical image registration could involve the spatial and temporal relationship among all the available image information [24] . The majority of the registration methods consist of landmarkbased registration, surface-based registration, and point intensity similarity measured-based registration. The transformation methods consist of rigid body transformation and non-rigid body transformation [25] [26] [27] . Most medical image registration algorithms additionally assume that the transformation is rigid body. However, the ultrasound images are acquired with a free-hand transducer. The transducer must be moved in a controlled way, and a three-dimensional dataset obtained for 3D image registration [28] .
Previous studies employed a rigid-body transformation [29] combined with a microUS/microPET multimodality phantom containing six image markers. A registration phantom with six markers was designed so that it could be placed in a small-animal holder. The procedure for constructing the registration phantoms is outlined in Fig. 1 . The phantom was made with 2% agarose solution. To prepare the alignment markers, six glass beads with a diameter of 0.43-0.60 mm were placed individually inside six holes created in the phantom. The holes were created with a diameter of 1 mm and the length of the column was around 3 mm. The six markers were into each hole using a microinjector, and the WF-3 ovarian tumor-bearing mouse was then fixed in the holder with the registration phantom. The tumor was implanted subcutaneously on the right shoulder of the C57BL/6J black mouse for 2 weeks [30] . After image reconstruction, the boundaries of the six markers were contoured and the center of gravity of each marker was calculated, and then the center of gravity of the six markers was used to perform the rigid-body registration transformation. These six markers were matched in the microUS and microPET images by using three image processing steps: (1) making the voxel size the same in the two imaging systems, (2) rigid-body image registration, and (3) fusing the images from the two systems. Evaluation of the image registration accuracy is necessary because the errors can be dragged into the registration process. The orthogonal Procrustes algorithm [31] was normally used for a rigid-body transformation, and the fiducial registration error (FRE) and the target registration error (TRE) was used to quantify the registration precision. In the microUS/ microPET registration system, the FRE ranged from 0.12 to 0.58 mm, with a mean of 0.31 mm [29] . The mean FRE and TRE of three registration phantoms are 0.68 and 1.05 mm, respectively [29] . TRE is generally larger than FRE, because the registration is performed based on the markers rather than the target. The registration precision is superior than microPET image resolution while inferior to microUS image resolution. Fig. 2 shows microUS/microPET fused (a) transverse, (b) sagittal, and (c) coronal views of a second-week tumor with registration markers. The microUS provides the tumor structure information with a gray map and microPET shows the radiopharmaceutical metabolism within the tumor region with a color map.
Noninvasive Tumor Imaging with MicroUS and MicroPET in Small Animals
The characteristics of microUS and microPET are presented in Table 1 [32, 33] . MicroPET imaging allows for both the temporal and the spatial biodistribution of a molecular probe to be determined in a single living animal model. [
18 F]FDG, a PET reporter probe, is able to provide both functional and metabolic information for the process of tumor growth in oncology [34] . However, a PET cyclotron is required to produce radioisotopes. The radiation has to be carefully shielded. The real-time nature of microUS on the other hand, is facilitating in anatomical and hemodynamic studies on small animals, such as mouse embryonic development, in vivo transgenic mouse disease models, and imageguided interventions on mice [7] [8] [9] .
3D microUS imaging and segmentation were reported and shown to be a reliable tool in the early detection and longitudinal growth analysis of xenograft tumors in mice [35] . MicroUS and 3D tumor segmentation and volume estimation were applied to tumors from 2 to 8 weeks after tumor implantation. The comparison between the three modalities was performed [36] .
The working flow chart of designing microUS/ microPET multimodality imaging for cancer research is outlined in Fig. 3 . After image registration, the tumors in microUS 3D small-animal images were segmented and 3D volume data were reconstructed. In [36] . Manual caliper measurements were affected by skin layers and surrounding nontumoral tissue, leading to an overestimation of tumor size. Nonetheless, the tumor volumes obtained from microPET imaging were even larger due to its insufficient spatial resolution. The over-estimation was primarily due to inadequate spatial resolution. In other words, the large extent of the point spread function of the imaging system caused the over-estimation. These results suggest that microUS is more reliable than microPET for tumor volume measurements at early stages. Moreover, in the late stages (5-8 weeks), standard deviations of microPET tumor volume measurements were large. The tumor boundary in microPET imaging is generally not clear after Table 1 . 5 weeks, possibly due to hypoxia and/or necrosis when the tumor grows bigger. The hypoxic or necrotic tumor areas do not uptake radiopharmaceuticals, thus making it difficult to define the contour in microPET imaging [37] .
Characteristics of microUS and microPET imaging modalities

Characterization of Focal Liver Lesions in Mice with 40 MHz CEUS Techniques
In Fig. 3 , for small animal study, CEUS imaging can evaluate tumor angiogenesis. Hepatocellular carcinoma (HCC) is a primary liver malignancy which mostly occurs in association with cirrhosis or chronic hepatitis in humans [14] [15] [16] [17] [18] [19] . CEUS imaging plays an important role in the clinical diagnosis of this disease, providing information on the hemodynamic changes of the HCC and aiding detection of the blood supply peculiar to HCC. Previous studies have found that HCC can be characterized by rapid intensity enhancement in the arterial phase (10-35 seconds after contrast injection), a rapid washout in the portal phase (30-120 seconds after contrast injection), and intensity enhancement of liver parenchyma in the parenchyma phase (120-360 seconds after contrast injection) [14] [15] [16] [17] [18] [19] . A non-linear response from microbubbles is based on two different mechanisms [20] [21] [22] [23] : one is a non-linear response from microbubble oscillations at low acoustic pressure, and the other is a high energy broadband non-linear response arising from microbubble disruption. In a previous study, the albumin-shelled microbubbles were used as the contrast agent and ultrasound B-mode imaging was done at low MI (0.188). In preclinical mouse liver metastasis models, high-frequency ultrasound imaging has been used to measure the tumor volume, assess metastatic progression, and evaluate chemotherapeutics [38, 39] . In a previous study, the imaging system and contrast agent were used to characterize three vascular contrast phases of focal liver lesions in Hepatitis B virus X (HBx) transgenic mice. The results were arranged according to the guidelines of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) [40] and histopathology findings. The typical enhancement patterns of benign lesions are summarized in Table 2 for the following lesions: haemangioma, FNH, focal fatty sparing, focal fatty change, regenerative nodules, cysts, adenoma, and abscesses [40] . The enhancement patterns for the characterization of malignant lesions (HCC, hypovascular metastases, hypervascular metastases, cholangio carcinoma) are summarized in Table 3 [40] .
Vascular phases in CEUS of the mice liver are arranged in Table 4 [41] . In Table 4 , the arterial phase ranges from 2 to 60 seconds post contrast injection. The time period from 10 to 30 minutes post contrast injection was defined as the parenchyma phase in this study. The pathology was characterized as a gold standard by a pathologist. The imaging results were compared with the pathology results, the sensitivity, specificity and accuracy of CEUS for the detection of malignant focal liver lesions in HBx transgenic mice were 91%, 100% and 92%, respectively. Fig. 5A shows the hypovascular metastases lesion in a mouse before contrast injection. In Fig. 5B , the hyper-enhancing feature was shown during the arterial phase. The hypoenhancing feature at 30 minutes after contrast injection is shown in Fig. 5C . The tumor entity was defined as the hypovascular metastases lesion by the image properties and histology (Fig. 5D ).
Contrast Improvement in Ultrasound Nonlinear Imaging Using Ensemble Empirical Mode Decomposition (EEMD)
For the data analysis and imaging improvement (Fig. 3) , ultrasound harmonic imaging with contrast agents takes advantage of the nonlinear response of the contrast agent. However, the contrast-totissue ratio (CTR) is still limited because significant harmonic echoes are also present in surrounding tissues. Instead of conventional filtering, the pulse inversion (PI) technique is an alternative method to extract the contrast harmonic signal [42] [43] [44] . HHT has recently been applied as an innovative signal processing technique in many diverse applications
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with success. It is a data analysis designed specifically for analyzing nonlinear and non-stationary signals. Empirical mode decomposition (EMD) is the key part of HHT proposed as an adaptive time-frequency analysis method for nonlinear and non-stationary data. A new EEMD method consists of an ensemble of decompositions of data with added white noise, and then treats the resultant mean as the final true result [45] . Compared to the contrast detection with fundamental and second harmonic imaging obtained using PI based nonlinear imaging, the CTRs in fundamental and second harmonic bands are improved by 9.9 and 4.2 dB after EEMD [46] .
Discussion and Conclusions
The combing methods of microUS and microPET multimodality imaging systems could be extended to integrate other imaging systems into these new techniques. For example, the homemade microbubbles could be generated as a multimodality contrast agent. The homemade ultrasound contrast Table 2 . Enhancement patterns of benign focal liver lesions in a human agent used in this study comprised microbubbles with albumin shells, and is similar to the commercial ultrasound contrast media Optison™ (GE Healthcare, Bucks, United Kingdom) [47, 48] The primary application of the proposed method is in cancer research on small-animal models. In such applications, microUS provides excellent anatomical information, whereas microPET provides information on glucose metabolism. Future studies could add CEUS imaging to evaluate the vascular phase in tumors. Since cancer drugs are delivered to the tumors via the vessels, such a multimodality approach represents an effective tool for both drug development and cancer research. In conclusion, microUS and microPET imaging techniques were applied for evaluating the tumor growth and progression. The results suggest that microUS is more reliable than microPET and traditional calipers in tumor volume analysis, especially when tumor volume is small. When the tumor is in its late stages, tumor hypoxia and necrosis can be detected by microPET. The combination of the anatomical information obtained from microUS and the metabolism information from microPET imaging, can be a valuable tool in cancer research. Image registration and fusion methods are being developed as the next step in realizing the potential of microUS/microPET multimodality imaging. Contrast-enhanced 40 MHz ultrasound imaging enhances the ability to detect three vascular phases and characterize malignant focal lesions, and would provide more information during experimental HCC treatments in small animal models. Moreover, the EEMD method for contrast improvement in ultrasound nonlinear imaging can help to develop the effectiveness of CEUS imaging. 
